Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Phytotherapy of benign prostatic hyperplasia. Current evidence-based evaluation].

K Dreikorn1, R Berges, L Pientka

  • 1Urologische Klinik, Zentralkrankenhaus, St.-Jürgen-Str., 28205 Bremen. Dreikorn@Uni-Bremen.de

Der Urologe. Ausg. A
|November 13, 2002
PubMed
Summary

Plant extracts for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) show some promise but require more rigorous trials. Further research is needed to confirm their effectiveness and tolerability for BPH treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The 27th annual meeting of the working group kidney transplantation of the German Society for Urology : November 21-24, 2019 in Halle (Saale)].

Der Urologe. Ausg. A·2019
Same author

[The 2018 annual report on the 26th annual meeting of the working group for kidney transplantation of the German Society of Urology in Berlin].

Der Urologe. Ausg. A·2019
Same author

[Report of the 24th annual conference of the Working Group Kidney Transplantation of the German Society of Urology in Erlangen].

Der Urologe. Ausg. A·2017
Same author

[Combined treatment of BPS with tamsulosin and finasteride : Literature review and prescription data].

Der Urologe. Ausg. A·2016
Same author

[Report of the 23rd annual meeting of the Working Group Kidney Transplantation of the German Society of Urology in Homburg (Saar)].

Der Urologe. Ausg. A·2016
Same author

[Erratum to: Generation Y - problem or solution in daily clinical practice].

Der Urologe. Ausg. A·2016

Area of Science:

  • Urology
  • Pharmacognosy
  • Evidence-Based Medicine

Background:

  • Plant extracts are popular for treating lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), used as medication in Europe and supplements in the US.
  • The clinical efficacy of these botanical agents for BPH remains a subject of debate and requires further investigation.

Purpose of the Study:

  • To evaluate the therapeutic potential of plant extracts in managing LUTS caused by BPH.
  • To assess the clinical effects and tolerability of commonly used plant extracts for BPH.

Main Methods:

  • Review of existing randomized clinical trials (RCTs) and meta-analyses focusing on plant extracts for BPH.
  • Consideration of studies on Serenoa repens, Pygeum Africanum, and pumpkin seeds.

Related Experiment Videos

  • Emphasis on trials adhering to evidence-based medicine criteria.

    • Main Results:

    • Limited high-quality RCTs with short follow-up periods exist.
    • Some meta-analyses and recent studies suggest clinical effects and good tolerability for Serenoa repens, Pygeum Africanum, and pumpkin seeds.
    • Evidence supporting widespread use is not yet conclusive.

    Conclusions:

    • While some plant extracts show potential benefits for LUTS due to BPH, their role is still controversial.
    • Additional randomized, placebo-controlled clinical trials with adequate follow-up are essential to definitively establish the therapeutic value of these botanical treatments for BPH.